Robert Dee Etherington - 18 Jul 2022 Form 4 Insider Report for Clene Inc. (CLNN)

Role: Chief Executive Officer, Director
Signature: /s/ Jerry Miraglia POA
Issuer symbol: CLNN
Transactions as of: 18 Jul 2022
Transactions value $: -$110,840
Form type: 4
Filing time: 19 Jul 2022, 16:08:31 UTC
Previous filing: 16 Feb 2022
Next filing: 07 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLNN	Common Stock	Sale	-$110,839	-23,483	-29%	$4.72^*	56,593	18 Jul 2022	Direct	F1
holding	CLNN	Common Stock						12,717	18 Jul 2022	By LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to be sold by Mr. Etherington to satisfy tax obligations in connection with the vesting of 80,076 restricted stock awards. The sales occurred automatically to satisfy tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan at a weighted average price of $4.72; the shares were sold in multiple transactions at prices ranging from $4.36 to $4.94, inclusive.
F2	The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.

Content

The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to be sold by Mr. Etherington to satisfy tax obligations in connection with the vesting of 80,076 restricted stock awards. The sales occurred automatically to satisfy tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan at a weighted average price of $4.72; the shares were sold in multiple transactions at prices ranging from $4.36 to $4.94, inclusive.

The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.